Alina Anton
Alina Anton has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gheorghe Solcan
Clinics Department, Faculty of Veterinary Medicine, “Ion Ionescu de la Brad” Iasi University of Life Sciences, M. Sadoveanu Alley 8, 700489 Iasi, Romania
2 shared publications - Alexandra-Andreea CherșUnaru
Faculty of Veterinary Medicine, Ion Ionescu de la Brad Iasi University of Life Science, 700489 Iasi, Romania
1 shared publication - Eugenia Dumitrescu
Department of Pharmacology and Pharmacy, University of Life Sciences “King Mihai I” from Timișoara, Calea Aradului 119, 300645 Timișoara, Romania
1 shared publication - Eusebiu Viorel Șindilar
Department of Surgery, Faculty of Veterinary Medicine, Iași University of Life Sciences “Ion Ionescu de la Brad”, 8 Mihail Sadoveanu Alley, 700489 Iasi, Romania
1 shared publication - Florin Nechifor
Reproduction, Clinics Department, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 8, Mihail Sadoveanu Alley, 700489, Iasi, Romania
1 shared publication Ioana Ștefania Cucoș
1 shared publication
Latest Publications
- 30 September 2026
- Published by Universitatea de Stiintele Vietii Regele Mihai I din Timisoara in Romanian Journal of Veterinary Sciences
- Vol. 59 (3) , 541-557
Sodium-glucose cotransporter 2 inhibitors versus insulin therapy in companion animals with diabetes mellitus: a systematic review of current evidence and therapeutic perspectives
Diabetes mellitus in companion animals represents a complex endocrine disorder with increasing prevalence, particularly in dogs and cats, requiring individualized and species-specific therapeutic approaches. This systematic review was conducted in accordance with the PRISMA 2020 Statement and compares two major therapeutic strategies—insulin therapy and sodium–glucose cotransporter 2 (SGLT2) inhibitors—while also analyzing factors influencing treatment selection, safety profiles, and emerging therapeutic perspectives. Insulin remains the cornerstone of diabetes management in both dogs and cats, providing reliable glycemic control across all disease stages, although its use is limited by the risk of hypoglycemia and the need for injectable administration and continuous monitoring. In contrast, SGLT2 inhibitors offer a novel oral, insulin-independent approach that improves owner compliance and demonstrates promising efficacy in selected stable feline patients, but their use is restricted by the risk of euglycemic ketoacidosis and limited applicability in insulin-dependent diabetes. Therapeutic decision-making is influenced by multiple factors, including species differences, disease pathophysiology, comorbidities, hepatic function, clinical experience, and owner-related constraints. Emerging therapies such as stem cell therapy, gene therapy, GLP-1 analogs, and advanced insulin delivery systems highlight the evolving landscape of veterinary diabetology and the potential for more personalized and regenerative treatment strategies in the future.
- 30 September 2026
- Published by Universitatea de Stiintele Vietii Regele Mihai I din Timisoara in Romanian Journal of Veterinary Sciences
- Vol. 59 (3) , 541-557
Sodium-glucose cotransporter 2 inhibitors versus insulin therapy in companion animals with diabetes mellitus: a systematic review of current evidence and therapeutic perspectives
Diabetes mellitus in companion animals represents a complex endocrine disorder with increasing prevalence, particularly in dogs and cats, requiring individualized and species-specific therapeutic approaches. This systematic review was conducted in accordance with the PRISMA 2020 Statement and compares two major therapeutic strategies—insulin therapy and sodium–glucose cotransporter 2 (SGLT2) inhibitors—while also analyzing factors influencing treatment selection, safety profiles, and emerging therapeutic perspectives. Insulin remains the cornerstone of diabetes management in both dogs and cats, providing reliable glycemic control across all disease stages, although its use is limited by the risk of hypoglycemia and the need for injectable administration and continuous monitoring. In contrast, SGLT2 inhibitors offer a novel oral, insulin-independent approach that improves owner compliance and demonstrates promising efficacy in selected stable feline patients, but their use is restricted by the risk of euglycemic ketoacidosis and limited applicability in insulin-dependent diabetes. Therapeutic decision-making is influenced by multiple factors, including species differences, disease pathophysiology, comorbidities, hepatic function, clinical experience, and owner-related constraints. Emerging therapies such as stem cell therapy, gene therapy, GLP-1 analogs, and advanced insulin delivery systems highlight the evolving landscape of veterinary diabetology and the potential for more personalized and regenerative treatment strategies in the future.
- Open Access
- 9 June 2023
- Published by MDPI AG in Preprints.org
The Effect of Drotaverine on Gastrointestinal Motility and Heart Rate Variability in Normal, Resting Horses
The impact of a non-anticholinergic spasmolytic drug (drotaverine hydrochloride) on 23 heart rate (HR), HR variability (HRV) and gastrointestinal tract (GIT) motility in the normal, resting 24 horses was determined. Ten adult riding horses had ECG recordings for 180 minutes after treat-25 ment with drotaverine (180 mg) or saline. Horses from the drotaverine group presented a de-26 creased of GIT contraction for two hours after treatment, but also showed drowsiness. Drotaverine 27 caused a reduction in cardiac vagal modulation of HR at T30 (P=0.050) and T60 (P=0.008) compared 28 to those receiving saline. RMSSD and high frequency (HF) recorded significantly low values after 29 drotaverine treatment by the end of the study, suggesting a decrease in parasympathetic activity. 30 HRV analysis indicated that drotaverine decreased both the low frequency (LF) and Lf/HF ratio 31 reflecting a decrease in sympathetic system. Non linear parameters registered low values after 32 drotaverine administration pointing a diminished in parasympathetic (for SD1) and sympathetic 33 (for SD2) activity. Decreased HRV was suggestive for a pervasive state of sympathetic hypervigi-34 lance of horses. The marked effect of drotaverine on HRV and GIT function in horses should be 35 taken into consideration when evaluating a clinical response to this drug in diseases associated 36 with smooth muscle spasm.
- 9 June 2023
- Published by MDPI AG in Preprints.org
Open AccessThe Effect of Drotaverine on Gastrointestinal Motility and Heart Rate Variability in Normal, Resting Horses
The impact of a non-anticholinergic spasmolytic drug (drotaverine hydrochloride) on 23 heart rate (HR), HR variability (HRV) and gastrointestinal tract (GIT) motility in the normal, resting 24 horses was determined. Ten adult riding horses had ECG recordings for 180 minutes after treat-25 ment with drotaverine (180 mg) or saline. Horses from the drotaverine group presented a de-26 creased of GIT contraction for two hours after treatment, but also showed drowsiness. Drotaverine 27 caused a reduction in cardiac vagal modulation of HR at T30 (P=0.050) and T60 (P=0.008) compared 28 to those receiving saline. RMSSD and high frequency (HF) recorded significantly low values after 29 drotaverine treatment by the end of the study, suggesting a decrease in parasympathetic activity. 30 HRV analysis indicated that drotaverine decreased both the low frequency (LF) and Lf/HF ratio 31 reflecting a decrease in sympathetic system. Non linear parameters registered low values after 32 drotaverine administration pointing a diminished in parasympathetic (for SD1) and sympathetic 33 (for SD2) activity. Decreased HRV was suggestive for a pervasive state of sympathetic hypervigi-34 lance of horses. The marked effect of drotaverine on HRV and GIT function in horses should be 35 taken into consideration when evaluating a clinical response to this drug in diseases associated 36 with smooth muscle spasm.
- Open Access
Recovery of Spinal Walking in Paraplegic Dogs Using Physiotherapy and Supportive Devices to Maintain the Standing Position
Paraplegic patients have always been ideal candidates for physiotherapy due to their body’s inability to recover on its own. Regardless of the cause that led to the onset of paraplegia (traumatic or degenerative), physiotherapy helps these patients with devices and methods designed to restore the proper functioning of their motility, as well as their quality of life. A total of 60 paraplegic dogs without deep pain in the hindlimbs caused by intervertebral disc extrusion or thoracolumbar fractures underwent physiotherapy sessions: manual therapy (massage), electrostimulation (10–20 min with possible repetition on the same day), ultrasound therapy, laser therapy, hydrotherapy, and assisted gait in supportive devices or on treadmills to stimulate and relearn walking, which was the main focus of the study. To maintain the standing position over time, we developed different devices adapted for each patient depending on the degree of damage and the possible associated pathologies: harnesses, trolleys, straps, exercise rollers, balancing platforms and mattresses, physio balls and rollers for recovery of proprioception. The main objective of our study was to demonstrate that physiotherapy and assisted gait in supportive devices to maintain the standing position may help paraplegic dogs to develop spinal walking. Concurrent pathologies (skin wounds, urinary infections, etc.) were managed concomitantly. Recovery of SW was evaluated by progression in regaining the reflectivity, nociception, gait score, and quality of life. After 125 to 320 physiotherapy sessions (25 to 64 weeks), 35 dogs (58.33%) developed spinal walking and were able to walk without falling or falling only sometimes in the case of a quick look (gait score 11.6 ± 1.57, with 14 considered normal), with a lack of coordination between the thoracic and pelvic limbs or difficulties in turning, especially when changing direction, but with the recovery of the quadrupedal position in less than 30 s. The majority of dogs recovering SW were of small size, with a median weight of 6.83 kg (range: 1.5–15.7), mixed breed (n = 9; 25.71%), Teckel (n = 4; 11.43%), Bichon (n = 5; 14.28%), Pekingese (n = 4; 11.43%), and Caniche (n = 2; 5.71%), while those who did not recover SW were larger in size, 15.59 kg (range: 5.5–45.2), and mixed breed (n = 16; 64%).
Open AccessRecovery of Spinal Walking in Paraplegic Dogs Using Physiotherapy and Supportive Devices to Maintain the Standing Position
Paraplegic patients have always been ideal candidates for physiotherapy due to their body’s inability to recover on its own. Regardless of the cause that led to the onset of paraplegia (traumatic or degenerative), physiotherapy helps these patients with devices and methods designed to restore the proper functioning of their motility, as well as their quality of life. A total of 60 paraplegic dogs without deep pain in the hindlimbs caused by intervertebral disc extrusion or thoracolumbar fractures underwent physiotherapy sessions: manual therapy (massage), electrostimulation (10–20 min with possible repetition on the same day), ultrasound therapy, laser therapy, hydrotherapy, and assisted gait in supportive devices or on treadmills to stimulate and relearn walking, which was the main focus of the study. To maintain the standing position over time, we developed different devices adapted for each patient depending on the degree of damage and the possible associated pathologies: harnesses, trolleys, straps, exercise rollers, balancing platforms and mattresses, physio balls and rollers for recovery of proprioception. The main objective of our study was to demonstrate that physiotherapy and assisted gait in supportive devices to maintain the standing position may help paraplegic dogs to develop spinal walking. Concurrent pathologies (skin wounds, urinary infections, etc.) were managed concomitantly. Recovery of SW was evaluated by progression in regaining the reflectivity, nociception, gait score, and quality of life. After 125 to 320 physiotherapy sessions (25 to 64 weeks), 35 dogs (58.33%) developed spinal walking and were able to walk without falling or falling only sometimes in the case of a quick look (gait score 11.6 ± 1.57, with 14 considered normal), with a lack of coordination between the thoracic and pelvic limbs or difficulties in turning, especially when changing direction, but with the recovery of the quadrupedal position in less than 30 s. The majority of dogs recovering SW were of small size, with a median weight of 6.83 kg (range: 1.5–15.7), mixed breed (n = 9; 25.71%), Teckel (n = 4; 11.43%), Bichon (n = 5; 14.28%), Pekingese (n = 4; 11.43%), and Caniche (n = 2; 5.71%), while those who did not recover SW were larger in size, 15.59 kg (range: 5.5–45.2), and mixed breed (n = 16; 64%).
- Open Access
A Case Study of Photosensitivity Associated with Anaplasma spp. Infection in Cattle
Anaplasma infection has not previously been reported as a cause of photosensitization. This case presents a five-year-old Holstein cow in her fifth month of gestation with skin injury of nonpigmented areas clearly delimited from adjacent unaffected pigmented skin. Specific lesions included alopecia, localized oedema, desquamation erythema, serous exudation, thick detached skin, fissures, crusting, and necrosis, indicating photodermatitis. Hematological abnormalities were leukocytosis with neutrophilia and normocytic hypochromic anemia. Based on a hemoparasitic examination of blood smears, the organism Anaplasma spp. was observed within the red blood cells. Biochemical analyses revealed increased serum liver enzyme activity associated with hepatocellular damage and cholestasis. This cow was RT-PCR positive for Anaplasma spp. infection. After treatment with oxytetracycline started, its condition improved within 24 h, and it recovered completely within 30 days. In this case, the underlying pathogenic mechanism of Anaplasma spp. infection facilitated the impairment of bile flow and liver function, resulting in hepatogenous photosensitization.
Open AccessA Case Study of Photosensitivity Associated with Anaplasma spp. Infection in Cattle
Anaplasma infection has not previously been reported as a cause of photosensitization. This case presents a five-year-old Holstein cow in her fifth month of gestation with skin injury of nonpigmented areas clearly delimited from adjacent unaffected pigmented skin. Specific lesions included alopecia, localized oedema, desquamation erythema, serous exudation, thick detached skin, fissures, crusting, and necrosis, indicating photodermatitis. Hematological abnormalities were leukocytosis with neutrophilia and normocytic hypochromic anemia. Based on a hemoparasitic examination of blood smears, the organism Anaplasma spp. was observed within the red blood cells. Biochemical analyses revealed increased serum liver enzyme activity associated with hepatocellular damage and cholestasis. This cow was RT-PCR positive for Anaplasma spp. infection. After treatment with oxytetracycline started, its condition improved within 24 h, and it recovered completely within 30 days. In this case, the underlying pathogenic mechanism of Anaplasma spp. infection facilitated the impairment of bile flow and liver function, resulting in hepatogenous photosensitization.